Literature DB >> 2242700

Sexually transmitted diseases of the colon, rectum, and anus. The challenge of the nineties.

S D Wexner1.   

Abstract

During the past two decades, an explosive growth in both the prevalence and types of sexually transmitted diseases has occurred. Up to 55 percent of homosexual men with anorectal complaints have gonorrhea; 80 percent of the patients with syphilis are homosexuals. Chlamydia is found in 15 percent of asymptomatic homosexual men, and up to one third of homosexuals have active anorectal herpes simplex virus. In addition, a host of parasites, bacterial, viral, and protozoan are all rampant in the homosexual population. Furthermore, the global epidemic of AIDS has produced a plethora of colorectal manifestations. Acute cytomegalovirus ileocolitis is the most common indication for emergency abdominal surgery in the homosexual AIDS population. Along with cryptosporidia and isospora, the patient may present to the colorectal surgeon with bloody diarrhea and weight loss before the diagnosis of human immunodeficiency virus (HIV) disease. Other patients may present with colorectal Kaposi's sarcoma or anorectal lymphoma, and consequently will be found to have seropositivity for HIV. However, in addition to these protean manifestations, one third of patients with AIDS consult the colorectal surgeon with either condylomata acuminata, anorectal sepsis, or proctitis before the diagnosis of HIV disease. Although aggressive anorectal surgery is associated with reasonable surgical results in some asymptomatic HIV positive patients, the same procedures in AIDS (symptomatic HIV positive) patients will often be met with disastrous results. It is incumbent upon the surgeon, therefore, to recognize the manifestations of HIV disease and diagnose these conditions accordingly.

Entities:  

Mesh:

Year:  1990        PMID: 2242700     DOI: 10.1007/bf02139224

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  12 in total

Review 1.  [Syphilis].

Authors:  W Krause
Journal:  Urologe A       Date:  2006-12       Impact factor: 0.639

Review 2.  Current concepts in anal fissures.

Authors:  Abraham A Ayantunde; Samuel A Debrah
Journal:  World J Surg       Date:  2006-12       Impact factor: 3.352

3.  In vitro microbicidal activities of cecropin peptides D2A21 and D4E1 and gel formulations containing 0.1 to 2% D2A21 against Chlamydia trachomatis.

Authors:  L M Ballweber; J E Jaynes; W E Stamm; M F Lampe
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

4.  Anorectal lesions in human immunodeficiency virus-infected patients.

Authors:  T Puy-Montbrun; J Denis; R Ganansia; F Mathoniere; N Lemarchand; N Arnous-Dubois
Journal:  Int J Colorectal Dis       Date:  1992-02       Impact factor: 2.571

Review 5.  Cytomegalovirus infection in the gastrointestinal tract.

Authors:  R Chetty; D E Roskell
Journal:  J Clin Pathol       Date:  1994-11       Impact factor: 3.411

Review 6.  Sexually transmitted infections of the anus and rectum.

Authors:  Roland Assi; Peter W Hashim; Vikram B Reddy; Hulda Einarsdottir; Walter E Longo
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

7.  Rectal syphilis mimicking rectal cancer.

Authors:  Jae Myung Cha; Sung Il Choi; Joung Il Lee
Journal:  Yonsei Med J       Date:  2010-02-12       Impact factor: 2.759

Review 8.  Advances in sexually transmitted infections of the gastrointestinal tract.

Authors:  Siew C Ng; Brian Gazzard
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-08-25       Impact factor: 46.802

9.  Brazilian Protocol for Sexually Transmitted Infections, 2020: sexually transmitted enteric infections.

Authors:  Edilbert Pelegrini Nahn Junior; Eduardo Campos de Oliveira; Marcelo Joaquim Barbosa; Thereza Cristina de Souza Mareco; Helena Andrade Brígido
Journal:  Rev Soc Bras Med Trop       Date:  2021-05-17       Impact factor: 1.581

10.  Is drinking water a risk factor for endemic cryptosporidiosis? A case-control study in the immunocompetent general population of the San Francisco Bay Area.

Authors:  Asheena Khalakdina; Duc J Vugia; Joelle Nadle; Gretchen A Rothrock; John M Colford
Journal:  BMC Public Health       Date:  2003-03-07       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.